A new paraclinical CSF marker for hypoxia-like tissue damage in multiple sclerosis lesions.
Lassmann H, Reindl M, Rauschka H, Berger J, Aboul-Enein F, Berger T, Zurbriggen A, Lutterotti A, Brück W, Weber JR, Ullrich R, Schmidbauer M, Jellinger K, Vandevelde M.
Lassmann H, et al. Among authors: berger j, berger t.
Brain. 2003 Jun;126(Pt 6):1347-57. doi: 10.1093/brain/awg127.
Brain. 2003.
PMID: 12764056
Free article.